Raymond James reiterates Strong Buy on Globe Life
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Raymond James maintained a Strong Buy rating and a $208 price target for Globe Life following executive meetings. The firm projects $850 million to $950 million in excess cash flow by 2027, supporting steady dividend growth and share repurchases. For investors, this signals potential long-term upside despite competitor concerns over medical claims volatility.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.